Product image of Beyfortus (Nirsevimab) supplied by GNH India

Beyfortus

Active Ingredient:
Nirsevimab
Origin:
EU

Beyfortus (Nirsevimab)

Beyfortus (Nirsevimab) is a respiratory syncytial virus (RSV) preventive medication administered intramuscularly. It is designed to protect infants and young children from RSV infections, a common cause of respiratory illness.

Manufacturer / TM Owner

Sanofi Winthrop Industrie

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Beyfortus is primarily used for the prevention of RSV infections in infants and young children. RSV is a common virus that can cause severe respiratory illness, particularly in young children. This medication is administered intramuscularly and is intended to provide protection against RSV during the season when the virus is most prevalent.

Side Effects

  • Beyfortus is designed to help prevent RSV infections, which can lead to symptoms such as coughing, wheezing, and difficulty breathing. By providing protection against RSV, Beyfortus aims to reduce the likelihood of these symptoms and the need for medical intervention.

Precautions & Warnings

  • Beyfortus should be administered by healthcare professionals. It is important to follow the recommended storage and handling instructions to ensure the medication remains effective. Always consult with a healthcare provider before administering Beyfortus, especially if the child has any known allergies or medical conditions.

Avoid Interactions

  • Beyfortus may interact with other medications, so it is important to inform your healthcare provider about all medications your child is currently taking. Specific interactions with alcohol or other substances have not been widely reported, but it is always best to consult with a healthcare professional for personalized advice.

Frequently Asked Questions

Beyfortus is used to prevent respiratory syncytial virus (RSV) infections in infants and young children.

Beyfortus is administered intramuscularly by a healthcare professional.

Beyfortus is designed to help prevent symptoms of RSV infections, such as coughing, wheezing, and difficulty breathing.

Yes, Beyfortus should be administered by a healthcare professional, and it is important to follow storage and handling instructions.

Beyfortus may interact with other medications, so it is important to inform your healthcare provider about all medications your child is taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nirsevimab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT